Valeant agrees to license Acanya in Actavis settlement

13-05-2014

Valeant agrees to license Acanya in Actavis settlement

Photo: Uros Zunic / Shutterstock.com

Canadian pharmaceutical company Valeant announced yesterday (May 12) that it had settled all litigation related to its acne treatment Acanya (clindamycin phosphate and benzoyl peroxide) with Actavis.


Valeant, Actavis, patent settlement, Acanya, Tiazac

LSIPR